BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.69), $0.70 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $253.7 million versus the consensus estimate of $259.62 million.

For earnings history and earnings-related data on BioScrip (BIOS) click here.